Evidence map›Paper›PMID 29339390›Full record

ArticleAntimicrobial agents and chemotherapy2018

Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity.

Dora Posfai, Amber L Eubanks, Allison I Keim, Kuan-Yi Lu, Grace Z Wang, Philip F Hughes, Nobutaka Kato, Timothy A Haystead, Emily R Derbyshire

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Inhibition ofFrontiers in parasitology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. The possibilities and challenges associated with selective targetingTransactions of the Royal Society of South Africa. Royal Society of South Africa · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Inhibitors of theCells · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Dora PosfaiDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA.
Amber L EubanksDepartment of Chemistry, Duke University, Durham, North Carolina, USA.
Allison I KeimDepartment of Chemistry, Duke University, Durham, North Carolina, USA.
Kuan-Yi LuDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA.
Grace Z WangDepartment of Chemistry, Duke University, Durham, North Carolina, USA.
Philip F HughesDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.
Nobutaka KatoThe Broad Institute, Cambridge, Massachusetts, USA.
Timothy A HaysteadDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.
Emily R DerbyshireDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA emily.derbyshire@duke.edu.
Duke University Hospital · USDuke University · USBroad Institute · USDuke Medical Center · US

Funding

Pharmacological Sciences Training ProgramT32GM007105 · NIGMS · DUKE UNIVERSITY · PI KUHN, CYNTHIA M · 1985 to 2019
$9.0M
Discovering new compounds to treat global infectious diseaseR00GM099796 · NIGMS · DUKE UNIVERSITY · PI DERBYSHIRE, EMILY R · 2014 to 2016
$747k
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
Discovering new compounds to treat global infectious diseaseK99GM099796 · NIGMS · HARVARD MEDICAL SCHOOL · PI DERBYSHIRE, EMILY R · 2013 to 2014
$120k
NIGMS NIH HHS K99 GM099796NIGMS NIH HHS R00 GM099796NIGMS NIH HHS T32 GM007105NIH HHS S10 OD018164
6 · The paper itself

Abstract

Malaria remains a global health burden partly due to

Indexed as

AntimalarialsBenzamidesHost-Pathogen InteractionsHSP90 Heat-Shock ProteinsHumansHydrazonesIndolesMalariaortho-AminobenzoatesPlasmodium falciparumSulfonamides2-fluoro-6-(tetrahydrofuran-3-ylamino)-4-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)benzamideAntimalarialsBenzamidesHSP90 Heat-Shock ProteinsHydrazonesIndolesortho-AminobenzoatesPIK 75Sulfonamideshost-pathogen interactionHsp90malariaPlasmodium

Identifiers

PMID29339390
PMCPMC5913967
OpenAlexW2783975198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.